Sequenom Ramps up Hiring, Licenses Additional Technology as it Nears Launch of T21 Test | GenomeWeb

By Monica Heger

This story was originally published Aug. 5.

As it readies the launch of a laboratory-developed version of its sequencing-based trisomy 21 test, Sequenom is adding to both its sales and clinical lab team, and has also licensed additional technology from longtime collaborator Dennis Lo of the Chinese University of Hong Kong, the company said last week in its quarterly earnings call with investors.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.